Join our Mission to Protect Humankind!
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, periodontitis and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.
Summary:
Looking for an energetic and talented individual to join our Analytical Development team. Primary responsibility for the incumbent will be to support the developmental activities currently on going in the laboratory as assigned.
Essential Functions:
- Assist in the design, execution, and interpretation of experiments to analyze drug substances and intermediates including:
- HPLC/LC-MS, IC, with experience in Chemstation
- Microplate assays
- SDS-PAGE, ELISA
- SEC-MALS
- GC-MS
- Assist in analytical method development of new assays.
- Support PCV stability programs on analyzing stability samples in a timely manner.
- Knowledge of capillary electrophoresis and/or experience in use of such would be a plus.
- Keep accurate and detailed records of experiments in laboratory notebooks.
- Summarize data and communicate to analytical team.
- Work within a team environment and provide support to further team objectives.
Requirements:
- B.S. in Chemistry, Analytical Chemistry preferred, Organic / Biochemistry considered with 2-6 years of relevant experience, or MS with 1-4 years of experience.
- The ideal candidate will have a background in analytical chemistry principles and hands-on experience with modern analytical instrumentations commonly used in the analysis and characterization of drug candidates. Candidates with other scientific disciplines may be considered based on relevant experience.
- Experience in chemical/biological/immunological assays such as HPLC/UV and other spectrometric methodology, ELISA, Western blots, CE-SDS, and SDS-PAGE.
- Experience in conjugate and carbohydrate analysis desired, for example in HPAEC-PAD, colorimetric methods, HPLC, SEC, and LC-MS.
- Understanding of basic principles of Analytical method development/ validation/ qualification concepts.
- Attention to detail and excellent skills in record keeping / documentation. Critical thinking and ability to analyze data.
- Strong interpersonal skills; ability to communicate effectively both verbally and in written formats.
- Ability to work under supervision in a fast-paced, cross-functional environment and collaborate effectively with other team members. Eagerness and ability to learn and understand new concepts with ease.
Reports to: Senior Scientist, Analytical Development
Location: San Carlos, CA
Compensation:
The compensation package will be competitive and includes comprehensive benefits and an equity component.
Salary Range: $105,000 – $114,000
Vaxcyte, Inc.
825 Industrial Road, Suite 300
San Carlos, CA 94070
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
Top Skills
What We Do
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and the XpressCFᵀᴹ cell-free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits. Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.
